visualvisitorlogo
  • Our Platform downarrow
    Powerful Sales
    Intelligence     dashboard
    Platform Overview
    Buyer Intent Data
    B2B Prospect Data     Website Visitor ID Email Tracking
  • Why?downarrow
    Your Challenges Our Data See For Yourself
  • Pricing
  • Resourcesdownarrow
    Resellers
    Add Onsdrop
    Call Tracking     Keyword Level Tracking Reputation Management
    Integrations About Us
    Contactdrop
    Atlanta Jacksonville
    Blog Careers Support
    • Login Free Trial Schedule A Demo
    × Our Platform downarrow
    Why? downarrow
    Pricing Resources downarrow
    visualvisitorlogo ☰

    Adgero Biopharmaceuticals

    Get Full Access

    Description

    • Adgero Biopharmaceuticals Holdings, Inc. is a privately-held biopharmaceutical company focused on building a pipeline by advancing its proprietary late stage photodynamic therapy (PDT) platform with broad utility for the treatment of serious oncology indications. Its lead product candidate, REM-001 Therapy, has demonstrated promising safety and efficacy in four Phase 2/3 clinical studies in patients with cutaneous metastatic breast cancer (CMBC) who have failed radiation therapy. Use of Adgero's existing data or the completion of a Phase 3 trial in individuals with CMBC could lead to approval of REM-001 Therapy.
    • location

      Headquarters:4365 Us 1 South Ste 211, Princeton, New Jersey, United States

      More
    • Adgero Biopharmaceuticals phone

      Phone Number: +1 609-917-9796

    • Adgero Biopharmaceuticals website

      Website: https://www.adgerobiopharm.com

    • Adgero Biopharmaceuticals employees

      Employees:3

    • Adgero Biopharmaceuticals revenue

      Revenue:$1 - 10M

    • Adgero Biopharmaceuticals legal name

      Legal Name:Adgero Biopharmaceuticals

    • Adgero Biopharmaceuticals's Social Media

      Adgero Biopharmaceuticals linkedin Adgero Biopharmaceuticals facebook Adgero Biopharmaceuticals twitter
    • done Is this data correct?

    • |  NAICS Code: 541713  |

      Show More
    Person level website identification

    CEO for Adgero Biopharmaceuticals

    Frank Pilkiewicz

    Chairman, Chief Executive Officer And President And Founder, Inc

    Person level website visitor identification

    Sell more in less time!

    Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!

    View Employees

    Frequently Asked Questions regarding Adgero Biopharmaceuticals

    • Where are Adgero Biopharmaceuticals's Headquarters?

      Adgero Biopharmaceuticals's Headquarters are in 4365 Us 1 South Ste 211,Princeton,New Jersey,United States

    • What is Adgero Biopharmaceuticals's phone number?

      Adgero Biopharmaceuticals's phone number is +1 609-917-9796

    • What is Adgero Biopharmaceuticals's official website?

      Adgero Biopharmaceuticals's official website is https://www.adgerobiopharm.com

    • What is Adgero Biopharmaceuticals's Revenue?

      Adgero Biopharmaceuticals's revenue is $1 - 10M

    • What is Adgero Biopharmaceuticals's NAICS code?

      Adgero Biopharmaceuticals's NAICS code is 541713

    • How many employees are working in Adgero Biopharmaceuticals

      Adgero Biopharmaceuticals has 3 employees

    • What is Adgero Biopharmaceuticals's Industry?

      Adgero Biopharmaceuticals is in the industry of Biotechnology

    • Who is Adgero Biopharmaceuticals's CEO?

      Adgero Biopharmaceuticals's CEO is Frank Pilkiewicz

    Company Directory